Skip to main content

Complementary Approaches for Military Women with Chronic Pelvic Pain: A Randomized Trial.

Publication ,  Journal Article
Crisp, CD; Baldi, R; Fuller, M; Abreu, E; Nackley, AG
Published in: J Integr Complement Med
January 2023

Introduction: Active duty (AD) women suffer with chronic pelvic pain (CPP) while providers tackle diagnoses and treatments to keep them functional without contributing to the opioid epidemic. The purpose of this randomized trial was to determine the effectiveness of noninvasive, self-explanatory mindfulness-based stress reduction (MBSR) or self-paced healthy lifestyle (HL) interventions on CPP in AD women. Methods: A 6-week, interventional prospective study with AD women aged 21-55 years at Mountain Home (MTHM), Idaho, was conducted. Women were randomly assigned to MBSR (N = 21) or HL (N = 20) interventions. The primary outcome was pain perception. The secondary outcomes were depression and circulating cytokine levels. Results: Women in the MBSR group exhibited reduced pain interference (p < 0.01) and depression (p < 0.05) alongside decreased interleukin (IL)-4 (p < 0.05), IL-6 (p < 0.05), eotaxin (p < 0.05), monocyte chemoattractant protein-1 (p = 0.06), and interleukin-1 receptor antagonist (IL-1ra) (p < 0.01) and increased vascular endothelial growth factor (p < 0.05). Women in the HL group did not have changes in pain; however, they did exhibit reduced depression (p < 0.05) alongside decreased granulocyte-macrophage colony-stimulating factor (p < 0.05) and increased tumor necrosis factor alpha (p < 0.05), stromal cell-derived factor-1 (p < 0.01), and IL-1ra (p < 0.01). Conclusions: AD women receiving MBSR or HL had reduced depression scores and altered circulating cytokine levels; however, only those receiving MBSR had reduced pain perception. Findings support MBSR as an effective and viable behavioral treatment for AD women suffering from CPP and provide premise for larger randomized controlled studies. Clinical Trial Registration: MOCHI-An RCT of mindfulness as a treatment for CPP in AD Women NCT04104542 (September 26, 2019).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Integr Complement Med

DOI

EISSN

2768-3613

Publication Date

January 2023

Volume

29

Issue

1

Start / End Page

22 / 30

Location

United States

Related Subject Headings

  • Young Adult
  • Vascular Endothelial Growth Factor A
  • Stress, Psychological
  • Randomized Controlled Trials as Topic
  • Prospective Studies
  • Pelvic Pain
  • Military Personnel
  • Middle Aged
  • Interleukin 1 Receptor Antagonist Protein
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Crisp, C. D., Baldi, R., Fuller, M., Abreu, E., & Nackley, A. G. (2023). Complementary Approaches for Military Women with Chronic Pelvic Pain: A Randomized Trial. J Integr Complement Med, 29(1), 22–30. https://doi.org/10.1089/jicm.2022.0616
Crisp, Carol D., Robert Baldi, Matthew Fuller, Eduardo Abreu, and Andrea G. Nackley. “Complementary Approaches for Military Women with Chronic Pelvic Pain: A Randomized Trial.J Integr Complement Med 29, no. 1 (January 2023): 22–30. https://doi.org/10.1089/jicm.2022.0616.
Crisp CD, Baldi R, Fuller M, Abreu E, Nackley AG. Complementary Approaches for Military Women with Chronic Pelvic Pain: A Randomized Trial. J Integr Complement Med. 2023 Jan;29(1):22–30.
Crisp, Carol D., et al. “Complementary Approaches for Military Women with Chronic Pelvic Pain: A Randomized Trial.J Integr Complement Med, vol. 29, no. 1, Jan. 2023, pp. 22–30. Pubmed, doi:10.1089/jicm.2022.0616.
Crisp CD, Baldi R, Fuller M, Abreu E, Nackley AG. Complementary Approaches for Military Women with Chronic Pelvic Pain: A Randomized Trial. J Integr Complement Med. 2023 Jan;29(1):22–30.

Published In

J Integr Complement Med

DOI

EISSN

2768-3613

Publication Date

January 2023

Volume

29

Issue

1

Start / End Page

22 / 30

Location

United States

Related Subject Headings

  • Young Adult
  • Vascular Endothelial Growth Factor A
  • Stress, Psychological
  • Randomized Controlled Trials as Topic
  • Prospective Studies
  • Pelvic Pain
  • Military Personnel
  • Middle Aged
  • Interleukin 1 Receptor Antagonist Protein
  • Humans